MSB 3.58% $1.45 mesoblast limited

Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-428

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,017 Posts.
    lightbulb Created with Sketch. 1545
    and nippy, I’ve been wanting to put this quote up for awhile ....

    ’Current’ group in FDA... going against the ODAC 9-1 vote in favour of REMESTEMCEL-L for treatment for SR-agvhd....

    https://hotcopper.com.au/data/attachments/2709/2709862-2538b855423ea83381b2c463f048e93c.jpg


    Last edited by Wilba32: 06/12/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.45
Change
0.050(3.58%)
Mkt cap ! $1.621B
Open High Low Value Volume
$1.41 $1.45 $1.40 $2.602M 1.829M

Buyers (Bids)

No. Vol. Price($)
12 34297 $1.45
 

Sellers (Offers)

Price($) Vol. No.
$1.45 444587 26
View Market Depth
Last trade - 12.13pm 11/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.